Global Regenerative Medicine Market

The global Regenerative Medicine Market was valued at USD 13.39 billion in 2016 and is projected to reach USD 89.75 billion by 2025, growing at a CAGR of 23.54% from 2017 to 2025.
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Availability of fund from Govt. and Private sector for development of regenerative medicine
1.2 Increasing cases of chronic diseases and genetic disorders
1.3 Increasing investments in global healthcare
1.4 Increase in corporate collaborations to enhance commercialization

2. Market Restraints
2.1 Ethical Concerns
2.2 Lack of Clear Regulatory Guidelines

Market Segmentation:
1. Global Regenerative MedicineMarket, by Therapy:
1.1 Cell Therapy
1.2 Tissue Engineering
1.3 Immunotherapy
1.4 Gene Therapy

2. Global Regenerative MedicineMarket, by Product:
2.1 Cell-Based Products
2.1.1 Allogeneic Products
2.1.2 Autologous Products
2.2 Acellular Products

3. Global Regenerative Medicine Market, by Application:
3.1 Orthopedic & Musculoskeletal Disorders
3.2 Dermatology
3.3 Cardiology
3.4 Central Nervous System Diseases
3.5 Oncology
3.6 Diabetes
3.7 Other Applications

4. Global Regenerative Medicine Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Acelity L.P. Inc. (KCI Licensing)
2. Nuvasive, Inc.
3. Vericel Corporation
4. Osiris Therapeutics, Inc.
5. Integra Lifesciences Corporation
6. Stryker Corporation
7. Medtronic PLC
8. Cook Biotech Incorporated
9. Organogenesis Inc.
10. Japan Tissue Engineering Co., Ltd. (Subsidiary of Fujifilm Holdings Corporation)
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Regenerative MedicineMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.